This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Addressing Both Sides of the Spectrum: New Approaches to Improved Outcomes for Naïve and Heavily Treatment—Experienced HIV Patients

Addressing Both Sides of the Spectrum: New Approaches to Improved Outcomes for Naïve and Heavily Treatment—Experienced HIV Patients

Format

Webcast

Time to Complete

1.25 hours

Released

July 31, 2019

Expires

July 31, 2020
Add to Queue


Maximum Credits

1.25 / AMA PRA Category 1 Credit(s)TM
1.25 / CE for Pharmacists

Accredited Provider

Jointly provided by Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare

In Collaboration With

The American Academy of HIV Medicine, the International Association of Providers of AIDS Care, and the University of Liverpool.

Commercial Supporter

Supported by an educational grant from Viiv Healthcare

Program Description

Because patients with HIV/AIDS are now living longer than ever before and taking antiretroviral therapy for decades, maximizing the safety and tolerability of treatment while preventing the development of resistance remains a high-stakes balancing act. As newer 2-drug regimens are now poised to challenge the standard of care for newly diagnosed individuals, clinicians must be knowledgeable of these options and prepared to incorporate them into practice. A small but important group of HIV-infected patients who also urgently require clinical attention are those considered “heavily treatment–experienced,” many of whom are failing on their current therapeutic regimen.

Intended Audience

HIV specialists, pharmacists, and primary care clinicians (MDs/DOs, physician assistants [PAs], and nurse practitioners [NPs]) who treat patients with HIV disease

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Describe and apply to practice recent data supporting the efficacy of dual-therapy regimens for initial treatment of HIV infection
  • Implement individualized therapeutic regimens that meet the needs of diverse patients with HIV while minimizing the risk for development of treatment resistance
  • Employ effective, evidence-based care plans for heavily treatment–experienced patients with HIV

Conflict Of Interest Disclosure Policies

In accordance with the ACCME Standards for Commercial Support, Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare, require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. Haymarket Medical Education and AKH Inc. resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.

Faculty

MODERATOR
David Alain Wohl, MD

The University of North Carolina School of Medicine
Site Leader, HIV Prevention and Treatment Clinical Research Site
Chapel Hill, NC

Dr. Wohl receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare.

FACULTY PRESENTERS
Eric S. Daar, MD

Professor of Medicine
David Geffen School of Medicine
University of California Los Angeles
Los Angeles, CA

Dr. Daar receives consulting fees from Gilead Sciences, Inc., and receives grant/research funding from Gilead Sciences, Inc., Merck and Co., Inc., and ViiV Healthcare.

Jürgen Rockstroh, MD
Professor of Medicine
Department of Medicine
University Hospital Bonn
Bonn, Germany

Dr. Rockstroh receives consulting fees from Abivax, Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare and is on the speakers’ bureaus of Gilead Sciences, Inc. and Merck and Co., Inc.

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Dr. Sax receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare and is a principal investigator for Gilead Sciences, Inc. and ViiV Healthcare.

Babafemi O. Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Feinberg School of Medicine
Chicago, IL

Dr. Taiwo receives consulting fees from GlaxoSmithKline (GSK), Janssen Therapeutics, Merck and Co., Inc., and ViiV Healthcare.

Laura Waters, FRCP, MD
Consultant Physician, Sexual Health & HIV
Mortimer Market Centre, Central & North West London NHS Trust
London, UK

Dr. Waters receives consulting fees from Gilead Sciences, Inc., Janssen Therapeutics, MSD, Mylan, and ViiV Healthcare and is on the speakers’ bureaus of Gilead Sciences, Inc. and ViiV Healthcare.

PHARMACY CONTENT REVIEWER
Dorothy Duffy, RPh, BS Pharmacy

Pharmacist
Van Houten Pharmacy
Clifton, NJ

Ms. Duffy has no financial relationships to disclose.

Accredited Provider Disclosures

Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.

Credit

1.25

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Haymarket Medical Education (HME) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 CreditsTM  to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has mutual recognition agreements with the AMA for live events and e-learning materials.

Credit

1.25

Type

CE for Pharmacists

Accreditation Statement

AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare (AKH) approves this knowledge-based activity for 1.25 contact hours (0.125 CEUs). UAN 0077-9999-19-042-H04-P. Initial release date: 7/31/2019.

Additional Credit Information

Physician Assistant Continuing Education
AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 Credit for completing this activity.

Nurse Practitioner Continuing Education
AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM   from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, AKH Inc., or ViiV Healthcare. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact HME at cmequestions@haymarketmedical.com.

If you have any other questions relating to your certificate or other issues with the activity, please contact
myCME.Support@haymarketmedical.com.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue